Are Weight Loss Drugs Dangerous? A UK Safety Guide (October 2026)

01 · The core answer

Are weight loss drugs dangerous, or just risky if misused?

Weight loss drugs are not inherently dangerous, but they are real medicines with real risks, and the risk changes sharply depending on where the product comes from and who is supervising it. Mounjaro (tirzepatide) is a once-weekly injectable prescription medicine made by Eli Lilly, licensed in the UK for weight management in adults and for type 2 diabetes.¹ It is supplied only after a consultation reviewed by a prescriber, and it is used alongside a reduced-calorie diet and increased physical activity.

That framing matters because the headlines about hospital cases and online sales tend to blur three different things: licensed medicines used as directed, licensed medicines obtained outside a clinical process, and products that are not what they claim to be. A fair answer treats them separately.

If you want a narrower look at the injections, our guides on whether weight loss jabs are dangerous and on the safety of GLP-1 drugs go into the same ground from those angles.

02 · Where the risk sits

How the risk differs by type of product

The first row is the only one where a clinician has decided the treatment is appropriate for you and is watching what happens. That is the single biggest safety feature, and it costs nothing extra to use it.

03 · Your decision

What to do if you are weighing this up

If you are considering treatment, the sensible next step is a consultation, not a purchase. Our free online consultation is a short health questionnaire, with no charge and no obligation, and it is reviewed by a GPhC-registered prescriber rather than a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.

Before that, work out three things for yourself. First, is your reason for wanting treatment a weight-related health concern that a clinician would recognise? Second, are you comfortable with a medicine you will inject once weekly and review regularly? Third, are you taking any other medicines, including insulin, sulfonylureas or an oral contraceptive pill, that your prescriber needs to know about? The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.¹ Doses of insulin and sulfonylureas may need adjusting because of the risk of low blood sugar, and Mounjaro can reduce absorption of oral contraceptives because stomach emptying slows.⁷

If that all sounds workable, you can see current options on our weight loss clinic page, or go straight to the Mounjaro pen prices and consultation. If it does not, or you are unsure, talking to your GP first is a perfectly reasonable choice. Our overview of weight loss drugs sets out the other options in plain terms.

04 · Where the danger really lies

Where the danger really lies: unregulated supply

The most serious avoidable danger with weight loss drugs is not the licensed medicine itself but how it reaches you. When a pen is sold by someone who offers to supply without a consultation or prescription, nobody has checked whether the medicine suits you, whether it interacts with something you already take, or whether the product in the box is genuine. Those are exactly the checks that make a prescription medicine safe to use.

The MHRA publishes counterfeit medicine alerts and runs the Yellow Card scheme, which is how suspicious products and suspected side effects are reported in the UK.⁷

A few practical signs that a seller is not a safe route:

• They will supply a prescription-only medicine without a consultation or prescription.
• They cannot show a pharmacy registration you can check on the public GPhC register.
• They promise specific results or dramatic weight-loss claims.
• The product is sold from social media, a messaging app or a marketplace listing with no pharmacy behind it.
• The price sits far below what established UK pharmacies charge for the same dose.

You can check any UK pharmacy on the GPhC public register.¹² Ours is registered as GPhC 9012878, and our Mounjaro comes through official LillyDirect supply, direct from Eli Lilly's UK distribution, as genuine KwikPens. Delivery is free next-day tracked in temperature-controlled, discreet packaging, which matters because these pens are kept cold.

Counterfeit pens are a particular worry because the outside of a pen tells you very little. If a pen arrives that looks different, has damaged packaging, or came from an unverified source, do not use it. Contact the seller, speak to a pharmacist, and report it through Yellow Card. The same applies if you have already used a product you now doubt: tell your GP or pharmacist what it was and how you took it so they can advise.

The broader point is that the label on a pen is not proof of what is inside it. The assurance comes from the chain behind it: a registered pharmacy, a licensed manufacturer, a prescriber who has reviewed you, and a documented supply route. When that chain is missing, the product is not a cheaper version of the same thing. It is a different risk entirely.

05 · Side effects and what to expect

Side effects: what the leaflet covers and how to act on it

Every prescription medicine can cause side effects, and Mounjaro is no exception. Common side effects are digestive: the most common, affecting more than 1 in 10 people, are nausea, diarrhoea, vomiting, constipation and abdominal discomfort. Side effects are most likely when starting treatment or moving up a dose, and for most people they ease within days to a few weeks as the body adjusts.¹¹³

Tirzepatide activates two natural gut-hormone receptors at once, GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹ A medicine that acts on digestion and appetite is one whose effects you will tend to notice in how you eat and feel after meals, which is why the leaflet is worth reading before your first dose rather than after something unexpected happens.

How to handle this in practice:

• Read the patient leaflet that comes with the pen before you inject.
• Tell your prescriber about any new or worrying symptom rather than waiting it out.
• Do not change your dose yourself, and never take extra doses to speed things up.
• Get medical help straight away for severe, persistent stomach pain that may spread to your back, pain in the upper right abdomen, fever or yellowing of the skin or eyes, or signs of a severe allergic reaction.
• Report suspected side effects through the Yellow Card scheme, which anyone can do.¹⁹

Our aftercare is built around this. Ongoing monthly reviews, dose-titration and follow-up assessments are carried out by the prescribing team, and side-effect support is part of the service. Repeat orders re-check suitability, and nothing ships automatically. That means a person is asked how treatment is going before the next pen is supplied, which is a safety net that unmonitored buying does not have.

The licensed approach starts at the lowest strength and steps up under supervision across the six strengths from 2.5mg to 15mg. Our guide on whether Mounjaro is dangerous to take for weight loss goes deeper on this particular medicine.

06 · Who should not take them

Who shouldn't take weight loss injections

Weight loss injections are not for everyone, and the decision about who they are not suitable for belongs to a prescriber working from the product information, not to a web page. Mounjaro is licensed for weight management in adults and for type 2 diabetes, and it is used alongside a reduced-calorie diet and increased physical activity.¹ It is a prescription-only medicine precisely because suitability needs checking first.

You should not take Mounjaro if you are allergic to tirzepatide or any of its ingredients, and it should not be used during pregnancy or while trying to conceive. Your prescriber will take extra care, or may recommend against treatment, if you have a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy, or gallbladder problems. Always share your full medical history and medicine list during consultation. Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly. What a consultation does is take your health history, current medicines and goals, and have a GPhC-registered prescriber decide whether treatment is appropriate. If it is not, the order is refunded automatically in full.

• Oral contraception. The medicine can reduce absorption of oral contraceptives because stomach emptying slows, so your prescriber needs to know if you use one. The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.⁷
• Insulin or sulfonylureas. Doses of these may need adjusting because of the risk of low blood sugar. That is a conversation about adjustment, not an automatic ban.
• Other medicines and supplements. List everything, including products bought without a prescription.
• Your weight and health history. Treatment is meant for adults with a weight-management need, not for anyone who simply wants to lose a little weight.

On eligibility for NHS treatment, NICE recommends Mounjaro for adults with a BMI of at least 35 plus at least one weight-related condition.⁴ Privately, Mounjaro is licensed for adults with a BMI of 30 or above, or a BMI between 27 and 30 with at least one weight-related condition such as high blood pressure, high cholesterol, obstructive sleep apnoea, cardiovascular disease, prediabetes or type 2 diabetes. A prescriber will tell you where you sit.

Honesty on the questionnaire is the most useful thing you can do for your own safety. It is tempting to adjust answers to be approved. Do not. The point of the review is to protect you, and a prescriber can only do that with accurate information. If you are unsure whether something matters, include it.

If a seller does not ask you these questions at all, that is the warning sign, not a convenience. A medicine that can interact with other treatments should never be handed over without someone asking what else you take. Our page on whether appetite suppressants are dangerous explains a similar logic for other products.

07 · Long-term effects and stopping

Long-term effects of Mounjaro and what happens when you stop

Long-term safety is a legitimate question, and it is something regulators and prescribers keep watching. Mounjaro is a licensed UK medicine, and the product information is updated as evidence accumulates. Regulators such as the EMA have reviewed signals on this class of medicines, including a safety review on a suspected mental-health signal, which is exactly how long-term monitoring is meant to work.¹⁷

Stopping is worth planning. Tirzepatide has a half-life of about five days, so after a final dose it takes roughly four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹ That is useful to know if you stop because of a side effect or a planned pause: the medicine does not vanish overnight, so effects do not necessarily end the same day either.

Mounjaro manages weight; it does not cure the biology behind it. In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average. Stopping should always be planned with your prescriber, with diet and activity habits ready to carry the load.¹⁴ The medicine works by helping you feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.¹ When that support is removed, the habits you built during treatment matter. A responsible service talks about this at the start, not at the end.

Practical steps for staying safe over the longer term:

• Keep attending reviews, even when things feel fine.
• Report new symptoms rather than assuming they are unrelated.
• Never stretch or skip doses to make a pen last longer, and never add extra doses.
• Tell any other clinician you see that you are on tirzepatide, especially before procedures or when starting new medicines.
• If you are pausing or stopping, tell your prescriber so your plan reflects the four to five weeks the medicine takes to clear.

It is also worth separating long-term from persistent. Many of the concerns people raise are about effects felt in the early weeks. Truly long-term data on this class of medicine is still developing, and anyone who claims a definitive answer to every long-term question is overselling.

If you have a specific long-term worry, such as a condition you already have, put it in writing in your consultation. It is far better to ask a prescriber about it before you start than to search for reassurance afterwards.

08 · Wegovy, Mounjaro and pills

Which is safer: Wegovy, Mounjaro or a weight loss pill?

Both are licensed UK treatments with their own Summary of Product Characteristics, and each has its own side-effect profile that you should read before choosing.¹¹⁸ Anyone who tells you one is flatly safer than the other is going beyond the evidence.

The differences you can describe honestly are about how they work and how you take them. Mounjaro activates two receptors, GIP and GLP-1, whereas semaglutide, the medicine in Wegovy and Ozempic, is a single-action GLP-1 medicine.¹ Wegovy comes as pens of 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg once weekly, stepping up after 4 weeks on each of 0.25mg, 0.5mg, 1mg and 1.7mg, with the 2.4mg maintenance dose starting from week 17. Mounjaro is stepped up across its six strengths under supervision. Liraglutide, sold as Saxenda and in other products, is a daily injection at a concentration of 6mg/ml, unlike the once-weekly options.

A head-to-head trial, SURMOUNT-5, does compare tirzepatide and semaglutide for weight loss, and our weight loss drugs overview sets out how the options differ. That trial is about effectiveness.

What about the safest weight loss pill? There are now licensed tablets, including Wegovy tablets and Foundayo, each with its own SmPC.²⁰²¹

The non-prescription market is a different matter. No over-the-counter product has the evidence base or the oversight of a licensed prescription medicine. Low-cost supplements and so-called natural alternatives are available cheaply without assessment, dosing is not standardised, and the dramatic weight-loss claims made for them are not supported in the way that licensed medicines' claims are. A phrase like nature's Ozempic is a marketing line, not a description of a medicine. If your goal is weight management, that is a conversation for a pharmacist or GP, not a shopping basket.

Older stimulant-style products are another category with a very different history. We cover them in our page on amphetamine drugs for weight loss, and we would encourage anyone considering them to read it first.

The practical rule is simple. Choose among licensed options with a prescriber, and let them match the medicine to your health history, your preferences and what you can sustain. Safety comes from that matching and from monitoring, more than from a league table.

09 · NHS versus private care

NHS versus private: the safety of each route

Both the NHS and regulated private prescribing are legitimate, supervised routes; the difference is access and speed, not whether one is safe and the other is not. Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first, initially BMI 40+ with four or more qualifying conditions.⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

For Wegovy, NHS access runs through specialist weight-management services; ask your GP about what is available locally.

If you are eligible for NHS treatment, it is worth asking about it. If you are not, or you do not want to wait, private treatment from a registered pharmacy is the next legitimate step. What matters for safety is that the private route includes the same safeguards you would expect elsewhere: a consultation, a prescriber who reviews it, a registered dispensing pharmacy and follow-up.

Our process works like this. A free online consultation is reviewed by a GPhC-registered prescriber. If approved, the medicine is dispensed by our registered pharmacy, with same-day dispatch when ordered by 3pm. Delivery is free next-day tracked, and Saturday delivery is £14.99. Needles, a sharps bin and injection guidance come with every order. Support is available Monday to Friday, 9am to 5pm, by email, account portal chat or phone.

Payment options include Visa, Mastercard, Klarna and pay-monthly plans, with no subscriptions.

Be wary of treating price as the only deciding factor. A very low price from an unregistered seller can cost you more in risk than a registered pharmacy's price costs you in money. Compare like with like: is there a consultation, a prescriber, a GPhC registration you can verify, and aftercare?

A reasonable approach for many people is to check NHS eligibility with a GP first, and consider the private route if they do not qualify or cannot wait. Either way, the principle is the same: a clinician decides, and someone follows up.

10 · Storing and injecting safely

Storing and injecting safely

Good handling is part of safe use, and it is simple once you know the rules. Mounjaro comes as a pre-filled multi-dose pen, the KwikPen, in six strengths from 2.5mg to 15mg.¹ Unopened pens are stored in the fridge, at 2–8°C, until first use, and they keep until the printed expiry date. Once in use, a UK KwikPen can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use, and must then be thrown away. Do not use a pen that has been above 30°C or has been frozen.¹³

For any question about an unopened pen that has been out of the fridge, such as after a delivery delay or a warm journey, do not guess. Check the patient information leaflet and contact the pharmacy. Using a pen outside its tested window means sterility and potency are no longer assured, and that is not a risk worth taking to save a pen.

Good habits to build from the first dose:

• Read the instructions for use that come with the pen, and follow them for how to prepare and inject.
• Use a new needle each time and dispose of used needles in the sharps bin supplied.
• Keep a note of your injection day so you do not double up by accident.
• Never share a pen with anyone, even if you change the needle.
• Never inject more than your prescribed dose, and do not take an extra dose to catch up.
• If you miss a dose, take it as soon as you can within 4 days (96 hours) of the scheduled time. If more than 4 days have passed, skip the missed dose and take the next one on your normal day; never take two doses within 3 days of each other.

A free companion app, GLPTrackr, is available for iOS and Android if you want to keep a record of your doses, how you feel and your progress. Having a log also makes your monthly reviews more useful, because you can give your prescriber specifics rather than impressions.

The same logic applies to dose changes. Moving up a strength is a prescriber decision, taken after review.

If something goes wrong, say a pen is damaged, a needle will not attach, or you think you have injected the wrong amount, stop and get advice. For a faulty, damaged or wrong item, contact us within three days. For anything that feels medically urgent, such as severe stomach pain, swelling of the face or throat or difficulty breathing, get medical help straight away or call 999. Treating handling as part of treatment, rather than an afterthought, removes a surprising share of avoidable problems.

11 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹